NCT04729478

Brief Summary

Drug-induced sleep endoscopy (DISE) is the most used technique for identifying the obstruction site associated with obstructive sleep apnea (OSA). This is due to the fact that it allows many patients to be examined in a daytime setting. This procedure uses sedative drugs to mimic natural sleep. However, associations with the site of upper airway (UA) collapse during natural sleep remain unclear. The aim of this explorative study is to identify UA collapse in patients with OSA using endoscopic techniques as well as flow shape characteristics and sound analyses during natural and drug-induced sleep. Furthermore, we want to optimize the measurement set-up of natural sleep endoscopy (NSE).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

March 30, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

July 26, 2021

Status Verified

July 1, 2021

Enrollment Period

1.4 years

First QC Date

January 26, 2021

Last Update Submit

July 19, 2021

Conditions

Keywords

Sleep endoscopySedationAirflow analysis

Outcome Measures

Primary Outcomes (1)

  • Endoscopic Classification System

    Comparison of the frequencies of the site, gradation and pattern of upper airway collapse between natural and drug-induced sleep endoscopy.

    Immediately, during the procedure

Secondary Outcomes (2)

  • Flow shape analysis

    Immediately, during the procedure

  • Acoustic analysis

    Immediately, during the procedure

Other Outcomes (9)

  • Apnea-hypopnea index (AHI)

    Immediately, during polysomnography

  • Oxygen desaturation index (ODI)

    Immediately, during polysomnography

  • Oxygen saturation (SaO2)

    Immediately, during polysomnography

  • +6 more other outcomes

Study Arms (2)

Natural sleep

OTHER

Natural sleep endoscopy (NSE) OSA patients will be endoscopically evaluated during natural sleep. During NSE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.

Device: Natural sleep endoscopy

Drug-induced sleep

OTHER

Drug-induced sleep endoscopy (DISE) OSA patients will be endoscopically evaluated during drug-induced sleep. During DISE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.

Device: Drug-induced sleep endoscopy

Interventions

An intravenous bolus injection of midazolam 1.5 mg will be used to induce sleep. Maintenance of sedated sleep will be obtained by a target-controlled infusion of propofol (2.0-3.0 µg/mL).

Also known as: DISE
Drug-induced sleep

Endoscopy during natural sleep.

Also known as: NSE
Natural sleep

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of OSA with a baseline AHI ≥ 15 per hour based on full polysomnography
  • Body mass index (BMI) ≤ 35 kg/m²
  • Capability of giving informed consent and willingness to undergo NSE

You may not qualify if:

  • Central sleep apnea (defined as CAHI ≥ 30% of total AHI)
  • Inability to sleep in a supine position due to a medical condition
  • Inability of the patient to understand and/or comply to the study procedures
  • Neuromuscular disorders or craniofacial anomalies affecting the UA
  • Sedative medication use (opioids and muscle relaxants)
  • Active psychiatric disorders (psychotic illness, major depression, anxiety attacks, excessive alcohol or drug use)
  • Severe or decompensated cardiac or respiratory diseases
  • Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, narcolepsy)
  • Contra-indications for DISE: i.e. fitness for general anesthesia (ASA\>3), allergy to sedative agent(s) and an expected extremely difficult airway
  • Pregnancy or willing to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antwerp University Hospital

Edegem, Antwerp, 2650, Belgium

RECRUITING

Related Publications (1)

  • Van den Bossche K, Van de Perck E, Wellman A, Kazemeini E, Willemen M, Verbraecken J, Vanderveken OM, Vena D, Op de Beeck S. Comparison of Drug-Induced Sleep Endoscopy and Natural Sleep Endoscopy in the Assessment of Upper Airway Pathophysiology During Sleep: Protocol and Study Design. Front Neurol. 2021 Dec 7;12:768973. doi: 10.3389/fneur.2021.768973. eCollection 2021.

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesDyssomniasSleep Disorders, IntrinsicSleep Wake DisordersNervous System Diseases

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersNeurologic Manifestations

Study Officials

  • Olivier Vanderveken, MD, PhD

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karlien Van den Bossche, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
NSE and DISE will be performed by two separate researchers, blinding the ENT surgeon who performs the NSE or DISE for the outcome of the other procedure. This is a blinded study and the researchers will have no knowledge of the patient's characteristics / demographic variables and their history.
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Blinded, prospective, single-center, comparative cohort study.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Olivier Vanderveken, Professor and Chair Otorhinolaryngology

Study Record Dates

First Submitted

January 26, 2021

First Posted

January 28, 2021

Study Start

March 30, 2021

Primary Completion

August 31, 2022

Study Completion

December 31, 2022

Last Updated

July 26, 2021

Record last verified: 2021-07

Locations